A detailed history of Dubuque Bank & Trust CO transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Dubuque Bank & Trust CO holds 3,257 shares of GILD stock, worth $286,876. This represents 0.03% of its overall portfolio holdings.

Number of Shares
3,257
Previous 3,257 -0.0%
Holding current value
$286,876
Previous $251,000 2.79%
% of portfolio
0.03%
Previous 0.03%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 17, 2023

BUY
$76.01 - $86.7 $34,204 - $39,015
450 Added 16.03%
3,257 $251,000
Q4 2022

Feb 03, 2023

BUY
$62.32 - $89.47 $174,932 - $251,142
2,807 New
2,807 $241,000
Q2 2022

Jul 13, 2022

BUY
$57.72 - $65.01 $192,149 - $216,418
3,329 New
3,329 $206,000
Q1 2022

May 03, 2022

SELL
$57.92 - $72.58 $194,089 - $243,215
-3,351 Closed
0 $0
Q4 2021

Jan 28, 2022

SELL
$64.88 - $73.64 $4,866 - $5,523
-75 Reduced 2.19%
3,351 $243,000
Q3 2021

Nov 09, 2021

BUY
$67.69 - $73.03 $4,196 - $4,527
62 Added 1.84%
3,426 $239,000
Q2 2021

Jul 09, 2021

SELL
$63.47 - $69.35 $110,056 - $120,252
-1,734 Reduced 34.01%
3,364 $232,000
Q1 2021

May 14, 2021

SELL
$60.0 - $68.46 $1,440 - $1,643
-24 Reduced 0.47%
5,098 $329,000
Q4 2020

Feb 10, 2021

BUY
$56.65 - $64.55 $23,453 - $26,723
414 Added 8.79%
5,122 $298,000
Q2 2020

Jul 24, 2020

SELL
$72.34 - $84.0 $11,863 - $13,776
-164 Reduced 3.37%
4,708 $362,000
Q1 2020

Apr 21, 2020

BUY
$62.63 - $80.22 $305,133 - $390,831
4,872 New
4,872 $365,000
Q2 2019

Jul 10, 2019

SELL
$61.87 - $69.38 $86,370 - $96,854
-1,396 Closed
0 $0
Q3 2018

Oct 30, 2018

SELL
$71.28 - $78.92 $1,069 - $1,183
-15 Reduced 1.06%
1,396 $108,000
Q2 2018

Jul 17, 2018

SELL
$64.88 - $75.68 $2,335 - $2,724
-36 Reduced 2.49%
1,411 $100,000
Q1 2018

May 10, 2018

SELL
$72.84 - $88.8 $1,602 - $1,953
-22 Reduced 1.5%
1,447 $109,000
Q4 2017

Feb 06, 2018

SELL
$71.15 - $83.52 $25,044 - $29,399
-352 Reduced 19.33%
1,469 $105,000
Q3 2017

Oct 13, 2017

BUY
$72.11 - $85.47 $131,312 - $155,640
1,821
1,821 $148,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Dubuque Bank & Trust CO Portfolio

Follow Dubuque Bank & Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dubuque Bank & Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Dubuque Bank & Trust CO with notifications on news.